OGN Straddle Strategy
OGN (Organon & Co.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions.
OGN (Organon & Co.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $3.50B, a trailing P/E of 14.12, a beta of 1.55 versus the broader market, a 52-week range of 5.69-13.44, average daily share volume of 9.1M, a public-listing history dating back to 2021, approximately 10K full-time employees. These structural characteristics shape how OGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.55 indicates OGN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. OGN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a straddle on OGN?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current OGN snapshot
As of May 15, 2026, spot at $13.39, ATM IV 3.80%, IV rank 0.57%, expected move 1.09%. The straddle on OGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this straddle structure on OGN specifically: OGN IV at 3.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a OGN straddle, with a market-implied 1-standard-deviation move of approximately 1.09% (roughly $0.15 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on OGN should anchor to the underlying notional of $13.39 per share and to the trader's directional view on OGN stock.
OGN straddle setup
The OGN straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OGN near $13.39, the first option leg uses a $13.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OGN chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $13.00 | $0.65 |
| Buy 1 | Put | $13.00 | $0.10 |
OGN straddle risk and reward
- Net Premium / Debit
- -$75.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$69.13
- Breakeven(s)
- $12.25, $13.75
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
OGN straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on OGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | +$1,224.00 |
| $2.97 | -77.8% | +$928.05 |
| $5.93 | -55.7% | +$632.10 |
| $8.89 | -33.6% | +$336.15 |
| $11.85 | -11.5% | +$40.20 |
| $14.81 | +10.6% | +$105.75 |
| $17.77 | +32.7% | +$401.70 |
| $20.73 | +54.8% | +$697.65 |
| $23.69 | +76.9% | +$993.60 |
| $26.65 | +99.0% | +$1,289.55 |
When traders use straddle on OGN
Straddles on OGN are pure-volatility plays that profit from large moves in either direction; traders typically buy OGN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
OGN thesis for this straddle
The market-implied 1-standard-deviation range for OGN extends from approximately $13.24 on the downside to $13.54 on the upside. A OGN long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current OGN IV rank near 0.57% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OGN at 3.80%. As a Healthcare name, OGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OGN-specific events.
OGN straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OGN alongside the broader basket even when OGN-specific fundamentals are unchanged. Always rebuild the position from current OGN chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on OGN?
- A straddle on OGN is the straddle strategy applied to OGN (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With OGN stock trading near $13.39, the strikes shown on this page are snapped to the nearest listed OGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are OGN straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the OGN straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 3.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$69.13 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a OGN straddle?
- The breakeven for the OGN straddle priced on this page is roughly $12.25 and $13.75 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OGN market-implied 1-standard-deviation expected move is approximately 1.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on OGN?
- Straddles on OGN are pure-volatility plays that profit from large moves in either direction; traders typically buy OGN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current OGN implied volatility affect this straddle?
- OGN ATM IV is at 3.80% with IV rank near 0.57%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.